Ductal Carcinoma
In Situ
403
mammography: first results of the Nijmegen Project, 1975–1981.
Lan-
cet
1984;1:1222–1224.
41. Ciatto S, Cataliotti L, Distante V. Nonpalpable lesions detected
with mammography: review of 512 consecutive cases.
Radiology
1987;165:99–102.
42. Meyer JS. Cell kinetics of histologic variants of
in situ
breast carci-
noma.
Breast Cancer Res Treat
1986;7:171–180.
43. Patchefsky AS, Shaber GS, Schwartz GF, et al. The pathology
of breast cancer detected by mass population screening.
Cancer
1977;40:1659–1670.
44. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma
in situ
:
mammographic findings and clinical implications.
Radiology
1989;170:411–415.
45. Ikeda DM, Andersson I. Atypical mammographic presentation of
ductal carcinoma
in situ
.
Radiology
1989;172:661–666.
46. Stomper PC, Connolly JL, Meyer JE, et al. Clinically occult ductal car-
cinoma
in situ
detected with mammography: analysis of 100 cases with
radiologic–pathologic correlation.
Radiology
1989;172:235–241.
47. D’Orsi CJ. Imaging for the diagnosis and management of ductal carci-
noma
in situ
.
J Natl Cancer Inst Monogr
2010;2010(41):214–217.
48. Carlson KL, Helvie MA, Roubidoux MA, et al. Relationship between
mammographic screening intervals and size and histology of ductal
carcinoma
in situ
.
AJR Am J Roentgenol
1999;172:313–317.
49. Holland R, Hendriks JHCL, Verbeek ALM, et al. Extent, distribution,
and mammographic/histological correlations of breast ductal carci-
noma
in situ
.
Lancet
1990;335:519–522.
50. Lagios MD. Multicentricity of breast carcinoma demonstrated by
routine correlated subgross and radiographic examination.
Cancer
1977;40:1726–1734.
51. Stomper PC, Connolly JL. Ductal carcinoma
in situ
of the breast: cor-
relation between mammographic calcification and tumor subtype.
AJR Am J Roentgenol
1992;159:483–485.
52. Parker J, Dance DR, Davies DH, et al. Classification of ductal carci-
noma
in situ
by image analysis of calcifications from digital mammo-
grams.
Br J Radiol
1995;68:150–159.
53. Evans A, Pinder S, Wilson R, et al. Ductal carcinoma
in situ
of the
breast: correlation between mammographic and pathologic findings.
AJR Am J Roentgenol
1994;162:1307–1311.
54. Evans AJ, Pinder SE, Ellis IO, et al. Correlations between the mam-
mographic features of ductal carcinoma
in situ
(DCIS) and c-erb-s
oncogene expression.
Clin Radiol
1994;49:559–562.
55. Han JS, Molberg KH, Sarode V. Predictors of invasion and axillary
lymph node metastasis in patients with a core biopsy diagnosis of duc-
tal carcinoma
in situ
: an analysis of 255 cases.
Breast J
2011;17:223–229.
56. Ciatto S, Grazzini G, Iossa A, et al.
In situ
ductal carcinoma of the
breast—analysis of clinical presentation and outcome in 156 consecu-
tive cases.
Eur J Surg Oncol
1990;16:220–224.
57. Mitnick JS, Roses DF, Harris MN, et al. Circumscribed intraductal
carcinoma of the breast.
Radiology
1989;170:423–425.
58. Park JS, Park YM, Kim EK, et al. Sonographic findings of high-grade
and non-high-grade ductal carcinoma
in situ
of the breast.
J Ultra-
sound Med
2010;29:1687–1697.
59. Reiff DB, Cooke J, Griffin M, et al. Ductal carcinoma
in situ
presenting
as a stellate lesion on mammography.
Clin Radiology
1994;49:396–399.
60. Menell JH, Morris EA, Dershaw DD, et al. Determination of the pres-
ence and extent of pure ductal carcinoma
in situ
by mammography
and magnetic resonance imaging.
Breast J
2005;11:382–390.
61. Gilles R, Zafrani B, Guinebretiere J-M,et al. Ductal carcinoma
in situ
:
MRimaging-histopathologiccorrelation.
Radiology
1995;196:415–419.
62. Orel S, SchnallM, Livolsi V, et al. Suspicious breast lesions:MR imaging
with radiologic–pathologic correlation.
Radiology
1994;190:485–493.
63. Heywang-Köbrunner S. Contrast-enhanced magnetic resonance im-
aging of the breast.
Invest Radiol
1994;29:94–104.
64. Orel SG, Mendonca MH, Reynolds C, et al. MR imaging of ductal car-
cinoma
in situ
.
Radiology
1997;202:413–420.
65. Pediconi F, Catalano C, Roselli A, et al. Contrast-enhanced MR mam-
mography for evaluation of the contralateral breast in patients with
diagnosed unilateral breast cancer or high-risk lesions.
Radiology
2007;243:670–680.
66. Londero V, Zuiani C, Linda A, et al. High-risk breast lesions at imag-
ing-guided needle biopsy: usefulness of MRI for treatment decision.
AJR Am J Roentgenol
2012;199:W240–W250.
67. Kuhl CK. Why do purely intraductal cancers enhance on breast MR
images?
Radiology
2009;253:281–283.
the Istituto Europeo di Oncologia (IEO), Milan, Italy.
Breast Cancer
Res Treat
2011;128:369–378.
13. Lakhani SR, Ellis IO, Schnitt SJ, et al.
WHO classification of tumours of
the breast
. 4th ed. Lyon: World Health Organization-IARC, 2012.
14.
. Accessed June
30, 2013.
15. Sacchini V, Fortunato L, Cody III HS, et al. Breast ductal carcinoma
in
situ
.
Int J Surg Oncol
2012;2012:753267.
16. Rosen PP. The pathological classification of human mammary carci-
noma: past, present and future.
Ann Clin Lab Sci
1979;9:144–156.
17. Smart CR, Myers MH, Gloecker LA. Implications from SEER data on
breast cancer management.
Cancer
1978;41:787–789.
18. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment
for ductal carcinoma
in situ
of the breast.
JAMA
1996;275:913–918.
19. Ernster VL, Barclay J. Increases in ductal carcinoma
in situ
(DCIS) of
the breast in relation to mammography: a dilemma.
J Natl Cancer Inst
Monogr
1997;(22):151–156.
20. Winchester DJ, Menck HR, Winchester DP. National treatment trends
for ductal carcinoma
in situ
of the breast.
Arch Surg
1997;132:660–665.
21. Blichert-Toft M, Graversen HP, Andersen J, et al.
In situ
breast carci-
nomas: a population-based study on frequency, growth pattern, and
clinical aspects.
World J Surg
1988;12:845–851.
22. Ward BA, McKhann CF, Ravikumar TS. Ten-year follow-up of breast
carcinoma
in situ
in Connecticut.
Arch Surg
1992;127:1392–1395.
23. Adams-Cameron M, Gilliland FD, Hunt WC, et al. Trends in in-
cidence and treatment for ductal carcinoma
in situ
in Hispanic,
American Indian, and non-Hispanic white women in New Mexico,
1973–1994.
Cancer
1999;85:1084–1090.
24. Shamliyan T, Wang SY, Virnig BA, et al. Association between patient
and tumor characteristics with clinical outcomes in women with ductal
carcinoma
in situ
.
J Natl Cancer Inst Monogr
2010;2010(41):121–129.
25. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast
cancer incidence, survival, and mortality rates.
J Natl Cancer Inst
1996;88:1571–1579.
26. Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma
in situ
of
the breast: a systematic review of incidence, treatment, and outcomes.
J Natl Cancer Inst
2010;102:170–178.
27. Kerlikowske K, Barclay J, Grady D, et al. Comparison of risk factors
for ductal carcinoma
in situ
and invasive breast cancer.
J Natl Cancer
Inst
1997;89:76–82.
28. Weiss HA, Brinton LA, Brogan D, et al. Epidemiology of
in situ
and invasive breast cancer in women aged under 45.
Br J Cancer
1996;73:1298–1305.
29. Virnig BA, Wang SY, Shamilyan T, et al. Ductal carcinoma
in situ
:
risk factors and impact of screening.
J Natl Cancer Inst Monogr
2010;2010(41):113–116.
30. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of
individuals with germline mutations in BRCA1 and BRCA2: analysis
of 10,000 individuals.
J Clin Oncol
2002;20:1480–1490.
31. Hall MJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2
mutations in women with breast carcinoma
in situ
and referred for
genetic testing.
Cancer Prev Res
(Phila) 2010;3:1579–1585.
32. Ciatto S, Bonardi R, Cataliotti L, et al. Intraductal breast carcinoma.
Review of a multicenter series of 350 cases.
Tumori
1990;76:552–554.
33. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal
carcinoma
in situ
in women undergoing screening mammography.
J Natl Cancer Inst
2002;94:1546–1554.
34. Andersson I. Breast cancer screening in Malmo.
Recent Results in Can-
cer Res
1984;90:114–116.
35. Andersson I, Andren L, Hildell J, et al. Breast cancer screening with
mammography. A population-based randomized trial with mammog-
raphy as the only screening mode.
Radiology
1979;132:273–276.
36. Hendricks JHCL.
Population Screening for Breast Cancer by Means
of Mammography in Nijmegen
, 1975–1982. [M.D. Thesis]. Nijmegen
University; 1982.
37. Lewis JD, Milbrath JR, Shaffer KA, et al. Implications of suspicious
findings in breast cancer screening.
Arch Surg
1975;110:903–907.
38. Sigfusson BF, Anderson I, Aspergren K, et al. Clustered breast calcifi-
cations.
Acta Radiol
1983;24:273–281.
39. Tabar L, Akerlund E, Gad A. Five-year experience with single-view
mammography randomized controlled screening in Sweden.
Recent
Results in Cancer Res
1984;90:105–113.
40. Verbeek ALM, Hendriks JHCL, Holland R, et al. Reduction of
breast cancer mortality through mass screening with modern
